Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Upper limb hemodynamics after infraclavicular brachial plexus block
ACTRN12613000872730Phase 4Completed
- Sponsor
- Military Hospital of Tunis
- Start
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of lidocaine and bupivacaine in end-stage kidney disease (ESKD), sponsored by Military Hospital of Tunis. Primary endpoints: Brachial artery blood flow, Cephalic vein diameter and 1 more. Started Jul 2013; status: completed.
02
Drugs
lidocainebupivacaine
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on ACTRN12613000872730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000872730.